Technology
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup
Synthesized from1 source
AI-generated summary
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup
OpenAI researcher Miles Wang is leaving the company to launch a startup focused on AI models for drug discovery, with talks to raise $200 million at a $2 billion valuation.
- Wang is leaving OpenAI to launch a startup focused on developing AI models for drug discovery.
- He is in talks to raise about $200 million at a $2 billion valuation, with Lightspeed in discussions to lead the round; talks are ongoing and may not finalize.
- Wang disputed the reported funding figures and description of the company but did not provide correct details.
- Several other OpenAI researchers are expected to join the new company.
Coverage
1 outlet — read the original reporting
Every story is brought together from multiple sources into a single, clear summary — with every perspective kept, not flattened.